Shetty Reshma P.
See remarks
Shetty Reshma P. has filed 3 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Oct 21, 2026.
On the most recent filing, Shetty Reshma P. is listed as See remarks at Ginkgo Bioworks Holdings, Inc. Inside the rolling window, Shetty Reshma P. reported no open-market purchases and 4 open-market sales totaling $1.4M in DNA. The largest disclosed transaction in the window is a sale of 124,727 DNA shares on Apr 10, 2026, worth $802K.
Companies traded
Other insiders at DNA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Shetty Reshma P. made?
Shetty Reshma P. has filed 3 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.
Which companies does Shetty Reshma P. trade?
Shetty Reshma P. has filed SEC Form 4 disclosures for 1 company, including DNA.
When was Shetty Reshma P.'s most recent SEC Form 4 filing?
Shetty Reshma P.'s most recent SEC Form 4 filing on Tracefour is dated Oct 21, 2026.
What is Shetty Reshma P.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Shetty Reshma P. is listed as See remarks.
What is Shetty Reshma P.'s total buy and sell value in the current window?
Inside the rolling retention window, Shetty Reshma P. bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Shetty Reshma P.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 124,727 DNA shares on 2026-04-10, worth $802K, per SEC Form 4 filings.